Single level spine fusion procedure typically entails removing the intervertebral disk (not shown) and inserting an interbody device into the disk space.
Current spine fusion procedures rely heavily on the use of posterior fixation to achieve the stability and rigidity necessary to obtain successful clinical results. However, implantation of posterior instrumentation necessarily involves removing important musculoskeletal elements.
Because of these concerns, anterior fixation systems have also been developed which require removal of much less musculoskeletal mass. However, because anterior fixation, especially in the abdominal or thoracic area, lies in close proximity to vital internal organs such as the aorta, these fixation systems must also possess a low profile.
In general, conventional intervertebral connection systems can be characterized by ligament components which are either a) relatively rigid, or b) not shaped for cooperative connection to bone fasteners, or by bone fasteners which are shouldered to seat upon the vertebral surface. When the ligament is relatively rigid, it must essentially fully lie upon the anterior surfaces of the adjacent vertebrae, thereby limiting design options. Systems having relatively rigid ligaments typically have transverse holes near their end portions for accepting bone fasteners. In systems in which the ligament is not shaped for cooperative attachment to the bone fastener, attachment is typically made by either suturing or by passing a screw through the ligament. When the bone fastener is seated upon the vertebral surface, a portion of the bone fastener protrudes from the surface and the tension of the ligament can not be further adjusted.
US patent application Ser. No. 2002/0143329 (“Serhan”) discloses a system in which a ligament has conformable portions and end portions shaped to cooperatively connect to shoulderless bone fasteners. The shoulderless feature of the bone fastener allows the bone fastener to be fully driven into the vertebral surface, thereby eliminating any problematic protrusion while also providing a means to adjust the tension of the ligament after the bone fasteners have been located. The conformable portions of the ligament allow the ligament to conform to the recess produced by a fully driven bone fastener without generating undue stress, thereby accommodating the surgeon's desire to fully drive the bone fastener within the recess. The cooperative shape of the ligament end portions allows for non-destructive attachment of the ligament to the bone fasteners without the use of sutures, thereby minimizing unwanted connection-related stresses and undesirable generation of foreign particles within the patient.
However, in many embodiments disclosed in Serhan, the bone fasteners are fixed to the bone by impaction. These impaction forces may compromise the integrity of the bone fastener component.
Moreover, the system disclosed in Serhan requires that the surgeon insert the system under tension and set or hold the tension while deploying the anchoring system. This makes the implantation procedures very arduous, and, due to high impaction forces, may not be suitable for use in certain areas of the spine.
The present inventors have developed intervertebral connection systems wherein the bone fastener has a helical shape. The helical shape allows installation and anchoring of the tensioning member (ligament) between two vertebral bodies or other bones without applying potential harmful impaction forces.
In preferred embodiments, the helical bone fastener has a hole at its distal end through which an end of the ligament is passed. This allows installation of the system without causing the ligament to twist or bind.
In some embodiments, the ligament is passed through an intermediate portion of the helix and then through the distal hole. When the helix is screwed into the bone when the system is provided in this conformation, the ligament rides up the helix, thereby providing in-situ tensioning of the ligament.
Therefore, in accordance with the present invention, there is provided an anchor having a central axis which is axially implantable into a bone in a patient's body, said anchor comprising:
Also in accordance with the present invention, there is provided an intervertebral connection system comprising:
Also in accordance with the present invention, there is provided a method of installing a bone fastening connection system, comprising the steps of:
Referring now to
In this particular embodiment, the inner surface 23 of the first helix has a helical groove 31 that extends along the length of the helix. This helical groove defines a helical groove diameter.
As shown, the helical groove 31 follows a same path as the first helix and has a pitch that is equal to a pitch of the first helix. As also shown, the first helix 21 includes multiple coils or windings having a space between adjacent coils or windings. The first helix 21 has a helical channel therein and defines a longitudinal bore, the longitudinal bore being in communication with the space between adjacent windings.
In some embodiments, the distal head portion has a first diameter and the first helix has a second diameter, and the first diameter is no greater than the second diameter. This ensures that the helical portion of the anchor will engage bone as the implant is driven into bone.
In some embodiments, the helix has an inner surface having a first thickness and an outer surface having a second thickness, and the first thickness is greater than the second thickness. This provides the helix with a radial sharpness that enhances its ability to engage bone. Preferably, the first thickness of the inner surface is at least three times greater than the second thickness of the outer surface.
Now referring to
In soft tissue applications, the flexibility of both the helix and soft tissue are such that the surgeon may simply insert the anchor into the soft tissue without having to engage in a threading procedure. Once inserted, the tool is removed and the tynes will anchor the soft tissue.
Now referring to
In this particular system, the first end portion 53 of the ligament has a first diameter DL, the throughhole has a second diameter DH, and the first diameter of the first end portion of the ligament is greater than the second diameter of the throughhole. The greater diameter of the first end portion of the ligament insures that the first end portion of the ligament will remain in its distal position vis-a-vis the bone anchor.
Also in this system, the first end portion of the ligament has a taper that increases in the proximal direction. This allows the first end portion of the ligament to pass more easily through the throughhole when the ligament in inserted into the anchor.
In some embodiments, the first end portion of the ligament has an outer surface 55 that is rounded. Preferably, this rounded cap is formed integral with the remainder of the ligament. In others (not shown), the first end portion has a conical taper.
In some embodiments, the first end portion of the ligament has a loop. This allows the surgeon to pass the ligament through the throughhole, and then attach a cross pin to the loop, thereby insuring that a portion of the ligament will remain distal to the anchor.
In other embodiments, the first end portion of the ligament is present in the from of an integral cap.
Now referring to
Therefore, also in accordance with the present invention, there is provided (claim 20) a kit for implanting a bone anchor, comprising:
Now referring to
Also in
Still referring to
Now referring to
Now referring to
In one especially preferred embodiment of the present invention, the system is intended to act as a temporary stabilization system for spine fusion procedures. That is, the system provides only temporary stabilization of the spine until the desired fusion can be achieved. Once fusion has been achieved, the system of this embodiment serves no further purpose. Therefore, in some embodiments, at least the central portion is made of a bioresorbable material. Preferably, the conformable portions are also made of a bioresorbable material. Preferably, the end portions of the ligament are also made of a bioresorbable material. Also preferably, the bone fasteners are also made of a bioresorbable material.
Preferred bioresorbable materials which can be used to make components of the present invention include bioresorbable polymers or copolymers, preferably selected from the group consisting of hydroxy acids, (particularly lactic acids and glycolic acids; caprolactone; hydroxybutyrate; dioxanone; orthoesters; orthocarbonates; and aminocarbonates. Preferred bioresorbable materials also include natural materials such as chitosan, collagen, cellulose, fibrin, hyaluronic acid; fibronectin, and mixtures thereof. However, synthetic bioresorbable materials are preferred because they can be manufactured under process specifications which insure repeatable properties.
A variety of bioabsorbable polymers can be used to make the device of the present invention. Examples of suitable biocompatible, bioabsorbable polymers include but are not limited to polymers selected from the group consisting of aliphatic polyesters, poly(amino acids), copoly(ether-esters), polyalkylenes oxalates, polyamides, tyrosine derived polycarbonates, poly(iminocarbonates), polyorthoesters, polyoxaesters, polyamidoesters, polyoxaesters containing amine groups, poly(anhydrides), polyphosphazenes, biomolecules (i.e., biopolymers such as collagen, elastin, bioabsorbable starches, etc.) and blends thereof. For the purpose of this invention aliphatic polyesters include, but are not limited to, homopolymers and copolymers of lactide (which includes lactic acid, D-,L- and meso lactide), glycolide (including glycolic acid), ε-caprolactone, p-dioxanone (1,4-dioxan-2-one), trimethylene carbonate (1,3-dioxan-2-one), alkyl derivatives of trimethylene carbonate, δ-valerolactone, β-butyrolactone, χ-butyrolactone, ε-decalactone, hydroxybutyrate, hydroxyvalerate, 1,4-dioxepan-2-one (including its dimer 1,5,8,12-tetraoxacyclotetradecane-7,14-dione), 1,5-dioxepan-2-one, 6,6-dimethyl-1,4-dioxan-2-one, 2,5-diketomorpholine, pivalolactone, χ,χ-diethylpropiolactone, ethylene carbonate, ethylene oxalate, 3-methyl-1,4-dioxane-2,5-dione, 3,3-diethyl-1,4-dioxan-2,5-dione, 6,8-dioxabicycloctane-7-one and polymer blends thereof. Poly(iminocarbonates), for the purpose of this invention, are understood to include those polymers as described by Kemnitzer and Kohn, in the Handbook of Biodegradable Polymers, edited by Domb, et. al., Hardwood Academic Press, pp. 251-272 (1997). Copoly(ether-esters), for the purpose of this invention, are understood to include those copolyester-ethers as described in the Journal of Biomaterials Research, Vol. 22, pages 993-1009, 1988 by Cohn and Younes, and in Polymer Preprints (ACS Division of Polymer Chemistry), Vol. 30(1), page 498, 1989 by Cohn (e.g. PEO/PLA). Polyalkylene oxalates, for the purpose of this invention, include those described in U.S. Pat. Nos. 4,208,511; 4,141,087; 4,130,639; 4,140,678; 4,105,034; and 4,205,399. Polyphosphazenes, co-, ter- and higher order mixed monomer-based polymers made from L-lactide, D,L-lactide, lactic acid, glycolide, glycolic acid, para-dioxanone, trimethylene carbonate and ε-caprolactone such as are described by Allcock in The Encyclopedia of Polymer Science, Vol. 13, pages 31-41, Wiley Intersciences, John Wiley & Sons, 1988 and by Vandorpe, et al in the Handbook of Biodegradable Polymers, edited by Domb, et al, Hardwood Academic Press, pp. 161-182 (1997). Polyanhydrides include those derived from diacids of the form HOOC—C6H4—O—(CH2)m—O—C6H4—COOH, where m is an integer in the range of from 2 to 8, and copolymers thereof with aliphatic alpha-omega diacids of up to 12 carbons. Polyoxaesters, polyoxaamides and polyoxaesters containing amines and/or amido groups are described in one or more of the following U.S. Pat. Nos. 5,464,929; 5,595,751; 5,597,579; 5,607,687; 5,618,552; 5,620,698; 5,645,850; 5,648,088; 5,698,213; 5,700,583; and 5,859,150. Polyorthoesters such as those described by Heller in Handbook of Biodegradable Polymers, edited by Domb, et al, Hardwood Academic Press, pp. 99-118 (1997).
Preferably, the bioresorbable material is selected from the group consisting of poly(lactic acid) (“PLA”) and poly(glycolic acid) (“PGA”), and copolymers thereof. These materials are preferred because they possess suitable strength and biocompatibility, display desirable resorption profiles, and have a long history of safe in vivo use. In general, PLA is a desirable because it typically has a resorption time exceeding 12 months, whereas PGA resorbs fairly quickly (having a resorption time of less than 12 months). However, PLA can require many years to completely resorb, and so is more likely to produce foreign-body reactions. Therefore, more preferably, the material is a PLA/PGA copolymer, more preferably the copolymer comprises between 80 wt % and 99 wt % lactic acid (as PLA), and between 1 wt % and 20 wt % glycolic acid (as PGA). Copolymers within these ranges provide the proper balance between the strength and the resorption time of the ligament.
Preferably, the bioresorbable component retains at least 50% of its tensile strength 6 months after implantation, but loses at least 50% of its tensile strength within 12 months of implantation. When this window of bioresorption is achieved, the component has the strength necessary to carry out its intended purpose during the time when bony fusion is occurring, but also bioresorbs after such fusion normally takes place. Also preferably, the bioresorbable polymer retains at least 50% of its mass 6 months after implantation, but loses at least 90% of its mass within 2 years of implantation. This may be accomplished by use of an 95/5 PLA/PGA copolymer.
In other embodiments, bioresorbable component comprises subintestinal submucosa (SIS).
Although bioresorbable materials are the preferred materials of construction for the components of the present invention, these components may be made from any material appropriate for human surgical implantation, including but not limited to all surgically appropriate metals including titanium, titanium alloy, chrome alloys and stainless steel, and non-metallic materials such as permanent or bioresorbable materials such as carbon fiber materials, resins, plastics and ceramics. If a nonbioresorbable material is selected, then preferred materials include polyesters, (particularly aromatic esters such as polyalkylene terephthalates, polyamides; polyalkenes; poly(vinyl fluoride); polyurethanes; polytetrafluoroethylene PTFE; carbon fibres; silk; and glass, and mixtures thereof.
In one preferred embodiment, both the compressible ligament and the bone fastener are each bioresorbable. The bioresorbable aspect of this device minimizes long term foreign body effects, while the compressible aspect minimizes the chances of short term failure by compressive loading.
In some embodiments, the helical bone fastener may be suitable used in conjunction with the intervertebral connection systems disclosed in US Published patent Application No. 2002/0143329 (Serhan), filed Mar. 30, 2001, the specification of which is hereby incorporated by reference in its entirety.
This application is a continuation of U.S. application Ser. No. 14/067,208, filed on Oct. 30, 2013, which is a continuation of U.S. application Ser. No. 13/309,462, filed on Dec. 1, 2011 (now U.S. Pat. No. 8,591,579), which is a division of U.S. application Ser. No. 11/139,961, filed on May 27, 2005 (now U.S. Pat. No. 8,092,528), each of which is hereby incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3672058 | Nikoghossian | Jun 1972 | A |
3988783 | Treace | Nov 1976 | A |
4105034 | Shalaby et al. | Aug 1978 | A |
4130639 | Shalaby et al. | Dec 1978 | A |
4140678 | Shalaby et al. | Feb 1979 | A |
4141087 | Shalaby et al. | Feb 1979 | A |
4205399 | Shalaby et al. | Jun 1980 | A |
4208511 | Shalaby et al. | Jun 1980 | A |
4570624 | Wu | Feb 1986 | A |
4863476 | Shepperd | Sep 1989 | A |
5049155 | Bruchman et al. | Sep 1991 | A |
5108431 | Mansat et al. | Apr 1992 | A |
5123926 | Pisharodi | Jun 1992 | A |
5197983 | Berman et al. | Mar 1993 | A |
5464929 | Bezwada et al. | Nov 1995 | A |
5522899 | Michelson | Jun 1996 | A |
5562671 | Goble et al. | Oct 1996 | A |
5591235 | Kuslich | Jan 1997 | A |
5595751 | Bezwada et al. | Jan 1997 | A |
5597579 | Bezwada et al. | Jan 1997 | A |
5607687 | Bezwada et al. | Mar 1997 | A |
5618552 | Bezwada et al. | Apr 1997 | A |
5620698 | Bezwada et al. | Apr 1997 | A |
5643319 | Green et al. | Jul 1997 | A |
5645850 | Bezwada et al. | Jul 1997 | A |
5648088 | Bezwada et al. | Jul 1997 | A |
5665122 | Kambin | Sep 1997 | A |
5681310 | Yuan et al. | Oct 1997 | A |
5698213 | Jamiolkowski et al. | Dec 1997 | A |
5700583 | Jamiolkowski et al. | Dec 1997 | A |
5766221 | Benderev et al. | Jun 1998 | A |
5769894 | Ferragamo | Jun 1998 | A |
5782917 | Carn | Jul 1998 | A |
5800543 | McLeod et al. | Sep 1998 | A |
5859150 | Jamiolkowski et al. | Jan 1999 | A |
5865846 | Bryan et al. | Feb 1999 | A |
5865848 | Baker | Feb 1999 | A |
5989256 | Kuslich et al. | Nov 1999 | A |
6045579 | Hochshuler et al. | Apr 2000 | A |
6086589 | Kuslich et al. | Jul 2000 | A |
6090998 | Grooms et al. | Jul 2000 | A |
6093205 | McLeod et al. | Jul 2000 | A |
6126689 | Brett | Oct 2000 | A |
6136001 | Michelson | Oct 2000 | A |
6176882 | Biedermann et al. | Jan 2001 | B1 |
6187009 | Herzog et al. | Feb 2001 | B1 |
6296656 | Bolduc et al. | Oct 2001 | B1 |
6332894 | Stalcup et al. | Dec 2001 | B1 |
6336940 | Graf et al. | Jan 2002 | B1 |
6379361 | Beck, Jr. et al. | Apr 2002 | B1 |
6387130 | Stone et al. | May 2002 | B1 |
6413278 | Marchosky | Jul 2002 | B1 |
6447517 | Bowman | Sep 2002 | B1 |
6554852 | Oberlander | Apr 2003 | B1 |
6562073 | Foley | May 2003 | B2 |
6576017 | Foley et al. | Jun 2003 | B2 |
6595998 | Johnson et al. | Jul 2003 | B2 |
6599320 | Kuslich et al. | Jul 2003 | B1 |
6616694 | Hart | Sep 2003 | B1 |
6652585 | Lange | Nov 2003 | B2 |
6656184 | White et al. | Dec 2003 | B1 |
6733535 | Michelson | May 2004 | B2 |
6752831 | Sybert et al. | Jun 2004 | B2 |
6835208 | Marchosky | Dec 2004 | B2 |
7022129 | Overaker et al. | Apr 2006 | B2 |
7104999 | Overaker | Sep 2006 | B2 |
7326248 | Michelson | Feb 2008 | B2 |
7503920 | Siegal | Mar 2009 | B2 |
7655010 | Serhan et al. | Feb 2010 | B2 |
7666226 | Schaller | Feb 2010 | B2 |
7670374 | Schaller | Mar 2010 | B2 |
7703727 | Selness | Apr 2010 | B2 |
7731751 | Butler et al. | Jun 2010 | B2 |
7785368 | Schaller | Aug 2010 | B2 |
7799081 | McKinley | Sep 2010 | B2 |
7837734 | Zucherman et al. | Nov 2010 | B2 |
7850733 | Baynham et al. | Dec 2010 | B2 |
7918874 | Siegal | Apr 2011 | B2 |
7942903 | Moskowitz et al. | May 2011 | B2 |
8007535 | Hudgins et al. | Aug 2011 | B2 |
8057544 | Schaller | Nov 2011 | B2 |
8092528 | Pellegrino et al. | Jan 2012 | B2 |
8105382 | Olmos et al. | Jan 2012 | B2 |
8206423 | Siegal | Jun 2012 | B2 |
8262666 | Baynham et al. | Sep 2012 | B2 |
8267939 | Cipoletti et al. | Sep 2012 | B2 |
8343193 | Johnson et al. | Jan 2013 | B2 |
8366777 | Matthis et al. | Feb 2013 | B2 |
8403990 | Dryer et al. | Mar 2013 | B2 |
8454617 | Schaller et al. | Jun 2013 | B2 |
8579981 | Lim et al. | Nov 2013 | B2 |
8591579 | Pellegrino et al. | Nov 2013 | B2 |
8961609 | Schaller | Feb 2015 | B2 |
20010007957 | Martin et al. | Jul 2001 | A1 |
20020040241 | Jarvinen | Apr 2002 | A1 |
20020120270 | Trieu et al. | Aug 2002 | A1 |
20020123750 | Eisermann et al. | Sep 2002 | A1 |
20020143329 | Serhan et al. | Oct 2002 | A1 |
20030028251 | Mathews | Feb 2003 | A1 |
20030078668 | Michelson | Apr 2003 | A1 |
20030078669 | Martin et al. | Apr 2003 | A1 |
20030088251 | Braun et al. | May 2003 | A1 |
20030130735 | Rogalski | Jul 2003 | A1 |
20030135275 | Garcia et al. | Jul 2003 | A1 |
20030139812 | Garcia et al. | Jul 2003 | A1 |
20030171811 | Steiner et al. | Sep 2003 | A1 |
20030187444 | Overaker et al. | Oct 2003 | A1 |
20030187446 | Overaker et al. | Oct 2003 | A1 |
20030195514 | Trieu et al. | Oct 2003 | A1 |
20030229350 | Kay | Dec 2003 | A1 |
20040002761 | Rogers et al. | Jan 2004 | A1 |
20040082956 | Baldwin et al. | Apr 2004 | A1 |
20040087947 | Lim et al. | May 2004 | A1 |
20040267278 | Overaker | Dec 2004 | A1 |
20050119752 | Williams et al. | Jun 2005 | A1 |
20060122701 | Kiester | Jun 2006 | A1 |
20060142858 | Colleran et al. | Jun 2006 | A1 |
20060235426 | Lim et al. | Oct 2006 | A1 |
20060276895 | Pellegrino et al. | Dec 2006 | A1 |
20070055272 | Schaller | Mar 2007 | A1 |
20070093901 | Grotz et al. | Apr 2007 | A1 |
20120143333 | Pellegrino et al. | Jun 2012 | A1 |
20120310352 | DiMauro et al. | Dec 2012 | A1 |
20130190875 | Shulock et al. | Jul 2013 | A1 |
20140058453 | Pellegrino et al. | Feb 2014 | A1 |
Number | Date | Country |
---|---|---|
197 10 392 | Jul 1999 | DE |
0 520 177 | Dec 1995 | EP |
1009471 | Dec 1999 | NL |
0067651 | Nov 2000 | WO |
0074605 | Dec 2000 | WO |
0267793 | Sep 2002 | WO |
0278574 | Oct 2002 | WO |
Entry |
---|
[No Author Listed] Arthrex Advertisement, Journal of Bone & Joint Surgery, Jan. 2005, vol. 87A, No. 1, Journal of Bone & Joint Surgery, Inc., USA, 3 pages. |
Allcock, Polyphosphazenes. The Encyclopedia of Polymer Science; 1988; pp. 31-41; vol. 13; Wiley Intersciences, John Wiley & Sons. |
Cohn, et al., Biodegradable PEO/PLA Block Copolymers. Journal of Biomedical Materials Research; 1988; pp. 993-1009; vol. 22; John Wiley & Sons, Inc. |
Cohn, Polymer Preprints. Journal of Biomaterials Research; 1989; p. 498; Biomaterials Research Labortatory, Casali Institute of Applied Chemistry, Israel. |
Heller, Poly (Otrho Esters). Handbook of Biodegradable Polymers; edited by Domb, et al., Hardwood Academic Press; 1997; pp. 99-118. |
Kemnitzer, Degradable Polymers Derived From the Amino Acid Ltyrosine. 1997; pp. 251-272; edited by Domb, et al., Hardwood Academic Press. |
Vandorpe, Biodegradable Polyphosphazenes for Biomedical Applications. Handbook of Biodegradable Polymers; 1997; pp. 161-182; Hardwood Academic Press. |
Number | Date | Country | |
---|---|---|---|
20160317283 A1 | Nov 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11139961 | May 2005 | US |
Child | 13309462 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14067208 | Oct 2013 | US |
Child | 15207078 | US | |
Parent | 13309462 | Dec 2011 | US |
Child | 14067208 | US |